Roivant Sciences Cash Flow Statement (2020-2025) | ROIV

Cash Flow Statement Jun2020 Sep2020 Dec2020 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-275.60M-101.08M-225.64M-632.80M-353.78M-315.92M-1054.60M-327.85M-86.10M-226.64M89.09M-43.08M373.19M
Share-based Compensation (Quarter)
-415.03M19.27M28.16M487.80M72.79M54.48M192.50M5.20M49.26M37.76M152.90M1.30M50.19M59.44M205.54M0.04M82.18M70.83M269.00M
Deferred Taxes (Quarter)
-50.00M
Asset Writedowns and Impairment (Quarter)
15.59M
Cash from Operations (Quarter)
-184.31M-141.17M-120.60M-530.26M-252.08M-189.63M-664.30M-249.93M-196.43M-656.81M-192.83M-266.81M-666.89M-204.38M-185.66M-586.53M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
25.04M54.30M11.06M9.82M29.61M
Amortization of Deferred Charges (Quarter)
5.40M2.00M2.19M6.01M1.62M1.70M5.05M1.58M1.58M4.87M1.94M1.94M6.41M
Depreciation & Amortization (CF) (Quarter)
4.23M2.68M5.08M12.90M5.84M5.59M16.81M4.88M4.84M12.65M1.10M0.92M2.71M
Change in Working Capital
Change in Account Payables (Quarter)
-59.21M-6.34M62.85M3.69M-19.45M26.23M13.97M11.94M-1.80M1.80M-25.27M7.21M-18.00M-11.74M3.00M-12.74M
Change in Accured Expenses (Quarter)
-19.57M-7.34M25.91M35.58M-18.18M19.62M5.70M-49.96M37.57M-15.79M-37.58M21.11M-19.51M-25.00M12.52M-3.90M
Other Working Capital Changes (Quarter)
36.45M-5.85M-3.28M-6.17M-3.13M-6.04M-3.34M-2.01M-12.56M-41.99M-12.27M8.82M-5.46M0.07M3.21M-2.11M
Investing Activities
Capital Expenditures (Quarter)
-3.38M2.34M2.76M11.17M7.46M3.10M11.07M0.40M0.28M1.03M0.96M1.00M3.79M4.04M7.85M6.95M
Sales of Property, Plant and Equipment (Quarter)
5,233.40M110.39M
Divestments (Quarter)
47.50M185.59M
Change in Acquisitions & Divestments (Quarter)
-320.17M320.17M960.00M720.00M1,105.00M2,745.00M
Cash from Investing Activities (Quarter)
-342.68M-2.34M317.41M309.00M-7.46M-146.85M-157.82M0.10M-36.45M5,196.69M-0.96M-3293.59M-2840.49M-1085.72M120.42M-855.82M
Financing Activities
Other financing activities (Quarter)
0.72M21.03M-20.44M51.02M2.27M6.62M37.01M30.06M-29.28M1.16M
Debt Issuance and Repayment
Short-Term Debt issuances (Quarter)
-36.40M36.40M36.40M159.90M159.90M
Change in Capital Stock
Shares Issued (Quarter)
80.36M51.61M154.63M154.27M153.05M148.75M91.67M147.07M37.56M42.24M107.48M139.41M135.59M
Net Equity Issued and Repurchased (Quarter)
94.73M199.82M
Dividend Payments
Dividends Paid - Common (Quarter)
6.00M
Misc.
Cash from Financing Activities (Quarter)
43.41M10.21M303.93M305.72M141.98M-7.34M289.13M7.48M207.87M451.99M-660.62M-109.07M-1042.64M-187.77M62.59M203.01M
Exchange Rate Effect (Quarter)
-0.12M-1.45M1.47M-2.74M5.04M1.24M0.81M1.21M2.45M
Change in Cash (Quarter)
-483.58M-133.30M500.75M84.46M-117.56M-343.82M-533.00M-242.47M-26.46M4,993.34M-857.15M-3664.43M-4548.78M-1477.05M-1.45M-1236.89M
Free Cash Flow (Quarter)
-180.92M-143.51M-123.36M-541.43M-259.54M-192.73M-675.37M-250.34M-196.70M-657.84M-193.79M-267.80M-670.67M-208.42M-193.51M-593.48M
Net Cash Flow (Quarter)
-483.58M-133.30M500.75M84.46M-117.56M-343.82M-533.00M-242.35M-25.01M4,991.87M-854.41M-3669.47M-4550.01M-1477.87M-2.65M-1239.34M